Method of treating wart
    7.
    发明授权
    Method of treating wart 失效
    治疗疣的方法

    公开(公告)号:US5560925A

    公开(公告)日:1996-10-01

    申请号:US316848

    申请日:1994-10-03

    IPC分类号: C07F7/30 C08G79/00 A61K9/20

    CPC分类号: C07F7/30 C08G79/00

    摘要: Wart of human being is prevented or cured by administration of a pharmaceutical composition containing an eight structural polymer of 2-oxygermylpropionic acid having an empirical formula of C.sub.6 H.sub.10 Ge.sub.2 O.sub.7, a minimum constitutional unit of (O.sub.1/2).sub.3 GeCH.sub.2 CH.sub.2 COOH and the following stereostructure: ##STR1## wherein R stands for --CH.sub.2 CH.sub.2 COOH and m is an integer of 137.+-.84.

    摘要翻译: 通过给药含有具有经验式为C 6 H 10 Ge 2 O 7的2-氧基甲基丙酸的八种结构聚合物的药物组合物,(O + E,fra 1/2 + EE)3GeCH 2 CH 2 COOH的最小结构单元和 以下立体结构:其中R代表-CH2CH2COOH,m是137 +/- 84的整数。

    Maillard reaction inhibitor
    8.
    发明授权
    Maillard reaction inhibitor 失效
    美拉德反应抑制剂

    公开(公告)号:US5621003A

    公开(公告)日:1997-04-15

    申请号:US515330

    申请日:1995-08-15

    CPC分类号: A61K31/80

    摘要: A maillard reaction inhibitor comprising, as the principal component, an eight-structural polymer of 3-oxygermylpropionic acid represented by the following stereostructure (I): ##STR1## wherein R represents --CH.sub.2 CH.sub.2 COOH, and m is a weight average polymerization degree calculated on the basis of the weight average molecular weight of propagermanium propyl ester and is 137.+-.84 (137 on average with a standard deviation of .+-.3.sigma.); and having the following minimum constitutional unit:(O.sub.1/2).sub.3 GeCH.sub.2 CH.sub.2 COOHand the following empirical formula:C.sub.6 H.sub.10 Ge.sub.2 O.sub.7,a method for inhibiting the Maillard reaction, and a method for preventing and treating diseases caused by Maillard reaction such as diabetes and concurrent diseases thereof.

    摘要翻译: 一种美拉德反应抑制剂,其包含由以下立体结构(I)表示的3-氧基甲基丙酸的8-结构聚合物作为主要组分:其中R表示-CH 2 CH 2 COOH,m表示重均聚合度 基于丙基丙基酯的重均分子量计算,为137 +/- 84(平均137个,标准偏差为+/- 3西格玛); 并具有以下最小结构单元:(O + E,fra 1/2 + EE)3GeCH 2 CH 2 COOH和以下经验式:C 6 H 10 Ge 2 O 7,抑制美拉德反应的方法,以及预防和治疗美拉德反应引起的疾病的方法 作为糖尿病及其并发疾病。